Intradigm Corporation

Patent Applications and Registrations

Patent applications and USPTO patent grants for Intradigm Corporation.The latest application filed is for "sirna compositions promoting scar-free wound healing of skin and methods for wound treatment".

Company Profile

0.6.25

Intradigm Corporation - Pal Alto CA
Intradigm Corporation - Palo Alto CA
INTRADIGM CORPORATION -
INTRADIGM CORPORATION - Germantown MD
Intradigm Corporation - Rockville MD
Intradigm Corporation - 12115 Parklawn Drive Suite K Rockville MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Sirna Compositions Promoting Scar-Free Wound Healing of Skin and Methods for Wound Treatment App 20120115923 - He; Wei-Wu ; et al.	2012-05-10
Heterobifunctional Polyethylene Glycol Reagents App 20110282093 - Levy; Daniel E. ; et al.	2011-11-17
Compositions Comprising Cmyc Sirna And Methods Of Use Thereof App 20110190375 - Xie; Frank Y.	2011-08-04
Composition And Methods Of Rnai Therapeutics For Treatment Of Cancer And Other Neovascularization Diseases App 20110124710 - Liu; Yijia ; et al.	2011-05-26
Compositions Comprising Notch1 Sirna And Methods Of Use Thereof App 20110105588 - Xie; Frank Y. ; et al.	2011-05-05
Compositions Comprising Human Pcsk9 And Apolipoprotein B Sirna And Methods Of Use App 20110065644 - Xie; Frank Y. ; et al.	2011-03-17
Compositions Comprising Nuclear Factor-kappa B (nf-kb) Sirna And Methods Of Use App 20110053861 - Xie; Frank Y. ; et al.	2011-03-03
Compositions Comprising Survivin Sirna And Methods Of Use Thereof App 20110053862 - Xie; Frank Y. ; et al.	2011-03-03
COMPOSITIONS COMPRISING HUMAN EGFR-siRNA AND METHODS OF USE App 20110046067 - Yang; Xiaodong ; et al.	2011-02-24
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases Grant 7,893,243 - Liu , et al. February 22, 2	2011-02-22
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases Grant 7,893,244 - Liu , et al. February 22, 2	2011-02-22
Inhibitory Polynucleotide Compositions And Methods For Treating Cancer App 20110038849 - Xie; Frank Y. ; et al.	2011-02-17
Methods And Compositions For Treatment Of Cancer And Other Angiogenesis-related Diseases App 20110015249 - Xie; Frank Y. ; et al.	2011-01-20
Compositions Comprising Stat3 Sirna And Methods Of Use Thereof App 20100298409 - Xie; Frank Y. ; et al.	2010-11-25
Compositions Comprising K-ras Sirna And Methods Of Use App 20100286241 - Xie; Frank Y. ; et al.	2010-11-11
Compositions Comprising Hif-1 Alpha Sirna And Methods Of Use Thereof App 20100280097 - Xie; Frank Y.	2010-11-04
Compositions Comprising Human Integrin-linked Kinase-sirna And Methods Of Use Thereof App 20100279919 - Xie; Frank Y.	2010-11-04
Compositions Comprising Stat5 Sirna And Methods Of Use Thereof App 20100273858 - Xie; Frank Y. ; et al.	2010-10-28
Composition and method of RNAi therapeutics for treatment of cancer and other neovascularization diseases Grant 7,786,092 - Liu , et al. August 31, 2	2010-08-31
Targets for tumor growth inhibition Grant 7,781,414 - Lu , et al. August 24, 2	2010-08-24
THERAPEUTIC siRNA MOLECULES FOR REDUCING VEGFR1 EXPRESSION IN VITRO AND IN VIVO App 20100210710 - Xie; Frank Y. ; et al.	2010-08-19
Targets For Tumor Growth Inhibition App 20100203036 - LU; PATRICK Y. ; et al.	2010-08-12
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases Grant 7,723,316 - Liu , et al. May 25, 2	2010-05-25
Compositions and Methods of Using siRNA to Knockdown Gene Expression and to Improve Solid Organ and Cell Transplantation App 20100028848 - Parker; Marie Denise ; et al.	2010-02-04
RNAi Therapeutics for Treatment of Eye Neovascularization Diseases App 20090247604 - Tang; Quinn ; et al.	2009-10-01
COMPOSITION AND METHODS OF RNAi THERAPEUTICS FOR TREATMENT OF CANCER AND OTHER NEOVASCULARIZATION DISEASES App 20090227657 - Liu; Yijia ; et al.	2009-09-10
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases Grant 7,534,878 - Liu , et al. May 19, 2	2009-05-19
Compositions For Treating Respiratory Viral Infections and Their Use App 20080279920 - Tang; Qingquan ; et al.	2008-11-13
Therapeutic methods for nucleic acid delivery vehicles App 20070219118 - Lu; Patrick ; et al.	2007-09-20
RNAI Agents For Anti-SARS Coronavirus Therapy App 20070203082 - Tang; Quinn T. ; et al.	2007-08-30
Methods of down regulating target gene expression in vivo by introduction of interfering rna App 20060211637 - Scaria; PuthupparampilV ; et al.	2006-09-21

Company Registrations

SEC

0001274506

INTRADIGM CORP

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.